Published 3 August 2020
This enhanced service provides seasonal flu vaccine to pre-school pupils using the nasal vaccine.
This service has two main purposes: to protect vulnerable young children against contracting the flu; and to reduce transmission to people who are at risk. The vaccine is delivered through a nasal spray.
It requires a proactive call system for the large majority of children who are not at particularly high risk from complications of flu, and a call and recall system for any child who has a health condition that makes them ‘at risk’. (This includes heart, lung, liver, neurological and immune diseases, diabetes, CSF leaks and cochlear implants.)
Patients must be under the age of four on 31 August but, as the delivery period runs from 1 September to 31 March, some will have their fourth birthdays before receiving the vaccine.
The enhanced service specification states specifically:
The specification advises that you should aim to complete routine immunisations by the end of November. If flu circulates in the community after that, clinicians are expected to use their own judgement about the needs of individual patients.
The specification states:
The vaccine information recommends two doses, four weeks apart, but there is little evidence of any additional benefit from the second dose. However, it is recommended that children should be given the second dose if they are at risk because of an underlying condition, such as asthma or diabetes.
The specification states:
The value to practices
The item of service fee is £10.06 per vaccination; a typical 5,000-patient practice could expect to earn around £2,500 with complete coverage. However, latest data indicate around 50% uptake amongst two- and three-year olds suggesting there is significant scope to improve coverage.
Vaccine can be ordered for free via ImmForm. The recommended vaccine is the live attenuated influenza vaccine (LAIV) nasal spray. Where patients are contra-indicated to the LAIV and are defined as at-risk, an alternative, egg-grown quadrivalent inactivated influenza vaccine (QIVe) will also be centrally supplied through ImmForm.
How to claim and ensure payment
Your practice must be signed up as delivering the service or ‘accepting a quality service’ on CQRS (Calculating Quality Reporting System) in order for payments to be made. The data are extracted via GPES (General Practice Extraction Service) run by NHS Digital.
You must enter the correct codes to trigger payment:
Payments are made monthly, after the final, completing dose. For manual claims, if GPES is not available, the cut-off point is 12 days after the end of the month in which the final dose was administered. For automated data collection, the deadline is five days after the end of the month.
Check the Open Exeter statement every month to ensure all the claims made correspond with monies and make sure that any errors are chased up swiftly. Any problems should be addressed initially with the commissioner (which is the CCG if operating delegated co-commissioning, or NHS England otherwise). CQRS and GPES errors can also be pursued via NHS Digital.
How to maximise coverage
Dr John Allingham is medical secretary at Kent LMC
Get Pulse Intelligence today instead of choosing a 30-day trial and access all features of the site, giving your practice everything you need to maximise financial potential.